Insider Stock Trading History of Miceli James T


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Miceli James T since year 2005. The trader's CIK number is 1385168. At the time of this reporting, Miceli James T is the 10% Owner of Immunosyn Corp . (stock ticker symbol NONE). See this page for all insider trading activities at Immunosyn Corp .


Stock purchases, sales, and option exercises reported by insider Miceli James T since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2009-07-27 IMYN Immunosyn Corp Buy 50,000 .07 3,500
2009-07-13 IMYN Immunosyn Corp Buy 10,000 .08 800
2009-08-31 IMYN Immunosyn Corp Buy 100,000 .05 5,000
2009-07-08 IMYN Immunosyn Corp Buy 36,500 .08 3,102
2009-07-10 IMYN Immunosyn Corp Buy 10,000 .09 900
2009-07-07 IMYN Immunosyn Corp Buy 10,000 .07 700
2009-07-06 IMYN Immunosyn Corp Buy 2,857 .06 171
2009-08-26 IMYN Immunosyn Corp Buy 77,000 .06 4,620
2009-07-28 IMYN Immunosyn Corp Buy 50,000 .07 3,500
2009-07-14 IMYN Immunosyn Corp Buy 50,000 .09 4,600
2009-07-15 IMYN Immunosyn Corp Buy 61,500 .09 5,658
2009-07-20 IMYN Immunosyn Corp Buy 12,780 .08 1,022
2009-06-30 IMYN Immunosyn Corp Buy 50,000 .07 3,500
2009-07-22 IMYN Immunosyn Corp Buy 52,500 .08 3,937
2007-11-01 IMYN Immunosyn Corp Sale 5,333 7.50 39,997
2007-10-24 IMYN Immunosyn Corp Sale 8,000 5.00 40,000
2007-10-18 IMYN Immunosyn Corp Sale 193,783 6.88 1,332,258
2007-10-03 IMYN Immunosyn Corp Sale 367,069 4.51 1,655,848
2007-06-12 IMYN Immunosyn Corp Sale 38,632 5.00 193,160
2007-08-24 IMYN Immunosyn Corp Buy 125,000 .00 0
2007-08-23 IMYN Immunosyn Corp Sale 192,470 4.85 933,479

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Miceli James T (10% Owner of Immunosyn Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.